Goldman Sachs
MESO icon

Goldman Sachs’s Mesoblast MESO Stock Holding History

Goldman Sachs’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100,000
Closed -$1.61M – 6678
2025
Q3 		$1.61M Buy
+100,000
New +$1.46M ﹤0.01% 4667

Other funds holding MESO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Arax Advisory Partners
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
FFA
Fi3 Financial Advisors Indianapolis, Indiana $418M AUM 35.26% 1-Year Est. Return
M&G plc
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

Goldman Sachs's MESO Position: Q2 2026 in Review

Goldman Sachs reduced its Mesoblast (MESO) stake by 0.4% in Q2 2026, selling an estimated $23.8K and leaving 395,612 shares worth $5.35M. The position accounts for ﹤0.01% of the portfolio, ranked #3825.

Goldman Sachs first reported a position in MESO in Q2 2016 and has held it in 21 quarters since. The position peaked at $7.14M in Q4 2025. 72 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

  • Goldman Sachs held 395,612 shares of Mesoblast worth $5.35M as of Q2 2026.
  • Goldman Sachs sold 1,603 Mesoblast shares in Q2 2026, an estimated $23.8K.
  • Mesoblast made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3825 holding.
  • Goldman Sachs first reported a position in Mesoblast in Q2 2016 and has held it in 21 quarters since.
  • Goldman Sachs's Mesoblast position peaked at $7.14M in Q4 2025.
  • 72 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.